FDA asks UroMed for more information:
This article was originally published in Clinica
Executive Summary
UroMed has received a request from the US FDA for more information on its Reliance urinary control insert, which has been granted expedited review status. An updated 510(k) was filed with the agency in August, after the FDA had requested additional information on the original application filed in December 1994. UroMed says it will file a response within 60 days, adding that it remains uncertain whether the FDA will accept the 510(k) or will require a PMA.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.